Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
+7.7M
-
Total reported value, excl. options
-
$190M
-
Value change
-
+$15.2M
-
Put/Call ratio
-
0.8
-
Number of buys
-
56
-
Number of sells
-
-28
-
Price
-
$1.83
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2022
115 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2022.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 237M outstanding shares and own 44.29% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.9M shares), BOOTHBAY FUND MANAGEMENT, LLC (10.4M shares), VANGUARD GROUP INC (8.14M shares), Nuveen Asset Management, LLC (7.59M shares), Stonepine Capital Management, LLC (7.13M shares), Magnetar Financial LLC (6.51M shares), Velan Capital Investment Management LP (5.82M shares), Clearline Capital LP (5.14M shares), AWM Investment Company, Inc. (4.68M shares), and BlackRock Inc. (4.11M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.